Shed vs Wellmedr: Coaching and Name-Brand Options vs Lower Prices
Quick answer: Shed emphasizes integrated coaching plus access to both name-brand and compounded GLP-1 options, while Wellmedr emphasizes lower starting prices, lifetime locked-in pricing and same-day review. If you want coaching bundled with access to name-brand drugs, Shed is the clearer fit; if upfront cost and locked pricing matter most, Wellmedr leads.
Explore Shed plans with coaching
Shed vs Wellmedr: How they differ at a glance
This comparison focuses on the most distinctive supported differences: medication options and regulatory notes, cost and pricing structure, coaching and care model, approval and shipping speed, and guarantees or offers. The primary keyword Shed vs Wellmedr appears throughout to keep the comparison focused.
1. Medication offerings and regulatory notes
Shed: Offers both FDA-approved name-brand GLP-1 medications and compounded alternatives. The source explicitly states Shed provides name-brand and compounded semaglutide and tirzepatide options. Shed’s materials include the regulatory qualifier that compounded medications are not FDA-approved and are prepared by a licensed pharmacy based on a provider’s prescription.
Wellmedr: Offers compounded GLP-1 medications exclusively from licensed U.S. pharmacies, with the same regulatory qualifier that compounded medications are not evaluated by the FDA for safety or efficacy. Wellmedr lists semaglutide and tirzepatide among available medications and notes specific product starting points in captured landing-page evidence.
See Wellmedr pricing and plans
2. Cost and pricing structure
Shed: Advertises compounded semaglutide injections starting at $199/month and compounded tirzepatide starting at $299/month, and a promotional 10% off your first month. Shed does not publish standard pricing across all plans and provides personalized quotes after intake; coaching is bundled into the monthly cost rather than charged separately.
Wellmedr: Lists GLP-1 plans starting at $89/month, with landing-page evidence that semaglutide plans can start lower on multi-month plans. Wellmedr promotes lifetime locked-in pricing and explicitly highlights no dose-based price increases in its captured materials.
3. Coaching and care model
Shed: Emphasizes continuous coaching integrated into treatment, not just a prescription. The source repeats that coaching is bundled and meant to support titration, lifestyle changes and plateaus. Shed positions this as a differentiator versus prescription-only competitors.
Wellmedr: The captured evidence centers on pricing guarantees, same-day review and shipping assurances rather than integrated coaching. The source does not provide captured evidence that Wellmedr bundles continuous coaching into every treatment plan.
4. Approval speed, shipping and guarantees
Shed: Uses a 2-minute approval assessment to check eligibility; a clinician review determines whether treatment is appropriate before a prescription is issued. Shed mentions a weight-loss guarantee with a Terms and Conditions reference for details.
Wellmedr: Highlights same-day review and free overnight shipping in the captured bullets and promotes on-time refills and a money-back guarantee statement on the landing page. Wellmedr also references a new-customer offer and lifetime discounts in captured evidence.
Comparison table: Shed vs Wellmedr
| Criteria | Shed | Wellmedr |
|---|---|---|
| Medication options | Name-brand and compounded GLP-1 | Compounded GLP-1 exclusively |
| Starting price (captured) | Compounded semaglutide starting at $199/month | Plans starting at $89/month |
| Pricing guarantees | 10% off first month for new patients; standard pricing provided after intake | Lifetime locked-in pricing; no dose-based price increases (captured) |
| Coaching and support | Continuous coaching integrated into treatment | Captured evidence highlights review and shipping; coaching not shown in capture |
| Approval and shipping | 2-minute assessment; clinician review required | Same-day review and free overnight shipping (captured) |
Direct evidence you can rely on
Shed’s materials repeatedly state it offers both FDA-approved name-brand GLP-1 and compounded options, continuous coaching, a 2-minute approval assessment, and a limited-time 10% off first month. Wellmedr’s captured landing page highlights GLP-1 plans starting at $89/month, lifetime locked-in pricing, no dose-based increases and same-day review plus shipping. Both note that compounded medications are not FDA-approved and are prepared by licensed pharmacies; both require clinician review before treatment.
Start Shed’s 2-minute assessment
Shed vs Wellmedr: Which should you choose?
Choose Shed if you want access to FDA-approved name-brand GLP-1 options alongside compounded alternatives and prefer continuous, integrated coaching as part of your treatment plan. Choose Wellmedr if upfront starting price, lifetime locked-in pricing and same-day review plus shipping are your top priorities.
Final note: This comparison uses only captured source evidence. Pricing, offers and availability cited above are taken directly from the captured materials and include qualifiers such as starting at, limited time offer, and clinician review required. Results may vary and compounded medications are not FDA-approved.